PTC THERAPEUTICS, INC. — Director's Dealing 2015

Jun 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-06-18

Reporting Person: Jacobson Allan Steven (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-18	Common Stock	S	5000	$50.13	Disposed	6848	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$51	2025-01-01	Common Stock (12000)	12000	Direct
Stock Option (right to buy)	$27.05	2024-01-27	Common Stock (10000)	10000	Direct
Stock Option (right to buy)	$10.85	2023-05-15	Common Stock (63000)	63000	Direct
Stock Option (right to buy)	$218.4	2022-01-10	Common Stock (83)	83	Direct
Stock Option (right to buy)	$490.8	2021-04-27	Common Stock (250)	250	Direct
Stock Option (right to buy)	$1149.6	2020-02-02	Common Stock (83)	83	Direct
Stock Option (right to buy)	$508.8	2019-10-07	Common Stock (83)	83	Direct
Stock Option (right to buy)	$626.4	2007-04-18	Common Stock (83)	83	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $49.89 to $50.36 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This option was granted on May 15, 2013 and vests over three years, with 8.33% of the shares underlying the option vested on August 15, 2013 and an additional 8.33% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter.

F4: Currently exercisable.